GBCMY (Global Bio-chem Technology Group Co) Long-Term Capital Lease Obligation : $0.0 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Global Bio-chem Technology Group Co Long-Term Capital Lease Obligation?

Global Bio-chem Technology Group Co's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.0 Mil.

Global Bio-chem Technology Group Co's quarterly Long-Term Capital Lease Obligation increased from Dec. 2023 ($0.0 Mil) to Jun. 2024 ($0.0 Mil) but then declined from Jun. 2024 ($0.0 Mil) to Dec. 2024 ($0.0 Mil).

Global Bio-chem Technology Group Co's annual Long-Term Capital Lease Obligation declined from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($0.0 Mil) but then increased from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($0.0 Mil).

Global Bio-chem Technology Group Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Global Bio-chem Technology Group Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Bio-chem Technology Group Co Long-Term Capital Lease Obligation Chart

Global Bio-chem Technology Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.29

0.04

0.03

Global Bio-chem Technology Group Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.04	-	-	0.04	0.03

Global Bio-chem Technology Group Co (OTCPK:GBCMY) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Global Bio-chem Technology Group Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Global Bio-chem Technology Group Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Bio-chem Technology Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Global Bio-chem Technology Group Co Ltd (OTCPK:GBCMY) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

00809:Hong Kong GLY:Germany

Address

The Metropolis Tower, 10 Metropolis Drive, Unit 1206, 12th Floor, Cheung Kei Center, Hung Hom, Kowloon, Hong Kong, HKG

Website

https://www.globalbiochem.com

Global Bio-Chem Technology Group Co Ltd manufactures and sells corn-refined products and corn-based biochemical products. Its segments are; Upstream products, Amino acids, corn sweeteners segment, and Polyol chemicals. The company generates a majority of its revenue from the Upstream products segment which engages in the manufacture and sale of corn starch, gluten meal, corn oil, and other corn refined products. Geographically, the firm generates a majority of its revenue from the People's Republic of China followed by the Americas, Asia, and other regions.

Global Bio-chem Technology Group Co Headlines

No Headlines